iSpecimen Inc. (ISPC)
NASDAQ: ISPC · Real-Time Price · USD
0.8267
-0.0421 (-4.85%)
At close: Oct 13, 2025, 4:00 PM EDT
0.8365
+0.0098 (1.19%)
After-hours: Oct 13, 2025, 7:59 PM EDT
iSpecimen Revenue
iSpecimen had revenue of $713.14K in the quarter ending June 30, 2025, a decrease of -75.10%. This brings the company's revenue in the last twelve months to $5.91M, down -43.77% year-over-year. In the year 2024, iSpecimen had annual revenue of $9.29M, down -6.42%.
Revenue (ttm)
$5.91M
Revenue Growth
-43.77%
P/S Ratio
0.23
Revenue / Employee
$246,170
Employees
24
Market Cap
4.58M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 9.29M | -637.07K | -6.42% |
| Dec 31, 2023 | 9.93M | -474.12K | -4.56% |
| Dec 31, 2022 | 10.40M | -733.00K | -6.58% |
| Dec 31, 2021 | 11.14M | 2.95M | 36.06% |
| Dec 31, 2020 | 8.18M | 3.89M | 90.40% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 422.82B |
| Johnson & Johnson | 90.63B |
| Merck & Co. | 63.62B |
| AbbVie | 58.33B |
| AstraZeneca | 56.50B |
| Novartis AG | 55.19B |
| Eli Lilly and Company | 53.26B |
| Novo Nordisk | 49.11B |
ISPC News
- 5 weeks ago - iSpecimen Approached by Crypto Currency Companies for $200 Million Treasury Discussions - Newsfile Corp
- 7 weeks ago - iSpecimen Announces Completion of Milestone 1 in Digital Transformation Journey with Salestack Platform - Newsfile Corp
- 2 months ago - iSpecimen to Establish $200M Corporate Treasury Built Around Solana Cryptocurrency with BlockArrow - Newsfile Corp
- 2 months ago - iSpecimen Inc. Announces Closing of Approximately $1.75 Million Private Placement Priced At-the-Market - GlobeNewsWire
- 2 months ago - iSpecimen Inc. Announces Pricing of Approximately $1.75 Million Private Placement Priced At-the-Market - GlobeNewsWire
- 2 months ago - Correction: iSpecimen Inc. Announces Closing of $4 Million Underwritten Offering - GlobeNewsWire
- 2 months ago - Correction: iSpecimen Inc. Announces Pricing of $4 Million Underwritten Offering - GlobeNewsWire
- 2 months ago - iSpecimen Inc. Announces Closing of $4 Million Underwritten Offering - GlobeNewsWire